Новые технологии в контроле течения сахарного диабета у детей (непрерывный мониторинг гликемии): о чем должен знать педиатр

1. Клинические рекомендации Минздрава России «Сахарный диабет 1 типа у детей», 2019 [Klinicheskie rekomendatsii Minzdrava Rossii “Sakharnyi diabet 1 tipa u detei”, 2019 (in Russian)].
2. Петеркова В.А., Емельянов А.О., Лаптев Д.Н., и др. Оценка эффективности амбулаторного наблюдения детей и подростков с сахарным диабетом 1-го типа при регулярном использовании профессионального непрерывного мониторинга уровня глюкозы. Проблемы эндокринологии. 2020;66(1):14-22 [Peterkova VA, Emelyanov AO, Laptev DN, et al. The efficacy of outpatient monitoring of children and adolescents with type 1 diabetes with regular use of professional continuous glucose monitoring. Problems of Endocrinology. 2020;66(1):14-22 (in Russian)]. DOI:10.14341/probl12200
3. Дедов И.И., Шестакова М.В., Петеркова В.А., и др. Сахарный диабет у детей и подростков по данным Федерального регистра Российской Федерации: динамика основных эпидемиологических характеристик за 2013–2016 гг. Сахарный диабет. 2017;20(6):392-402 [Dedov II, Shestakova MV, Peterkova VA, et al. Diabetes mellitus in children and adolescents according to the Federal diabetes registry in the Russian Federation: dynamics of major epidemiological characteristics for 2013−2016. Diabetes Mellitus. 2018;20(6):392-402 (in Russian)]. DOI:10.14341/DM9460
4. El-Laboudi AH, Godsland IF, Johnston DG, Oliver NS. Measures of glycemic variability in type 1 diabetes and the effect of real-time continuous glucose monitoring. Diabetes Technol Ther. 2016;18(12):806-12. DOI:10.1089/dia.2016.0146
5. Danne T, Nimri R, Battelino T, et al. International Consensus on Use of Continuous Glucose Monitoring. Diabetes Care. 2017;40(12):1631-40. DOI:10.2337/dc17-1600
6. Petrie JR, Peters AL, Bergenstal RM, et al. Improving the clinical value and utility of CGM systems: issues and recommendations: A joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group. Diabetologia. 2017;60(12):2319-28. DOI:10.1007/s00125-017-4463-4
7. Демидова Т.Ю., Ушанова Ф.О. Современные технологии непрерывного мониторинга гликемии: развивающиеся возможности контроля и управления. РМЖ. 2018;11(II):86-90 [Demidova TYu, Ushanova FO. Modern technologies for continuous monitoring of glycemia: developing opportunities for check-up and control. RMJ. 2018;11(II):86-90 (in Russian)].
8. Суплотова Л.А., Судницына А.С., Романова Н.В., Шестакова М.В. Время нахождения в целевом диапазоне гликемии – инструмент оценки качества гликемического контроля при сахарном диабете. Сахарный диабет. 2021;24(3):282-90 [Suplotova LA, Sudnitsyna AS, Romanova NV, Shestakova MV. Time in range is a tool for assessing the quality of glycemic control in diabetes. Diabetes Mellitus. 2021;24(3):282-90 (in Russian)]. DOI:10.14341/DM12703
9. Battelino T, Danne T, Bergenstal RM, et al. Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range. Diabetes Care. 2019;42(8):1593-603. DOI:10.2337/dci19-0028

________________________________________________

1. Klinicheskie rekomendatsii Minzdrava Rossii “Sakharnyi diabet 1 tipa u detei”, 2019 (in Russian).
2. Peterkova VA, Emelyanov AO, Laptev DN, et al. The efficacy of outpatient monitoring of children and adolescents with type 1 diabetes with regular use of professional continuous glucose monitoring. Problems of Endocrinology. 2020;66(1):14-22 (in Russian). DOI:10.14341/probl12200
3. Dedov II, Shestakova MV, Peterkova VA, et al. Diabetes mellitus in children and adolescents according to the Federal diabetes registry in the Russian Federation: dynamics of major epidemiological characteristics for 2013−2016. Diabetes Mellitus. 2018;20(6):392-402 (in Russian). DOI:10.14341/DM9460
4. El-Laboudi AH, Godsland IF, Johnston DG, Oliver NS. Measures of glycemic variability in type 1 diabetes and the effect of real-time continuous glucose monitoring. Diabetes Technol Ther. 2016;18(12):806-12. DOI:10.1089/dia.2016.0146
5. Danne T, Nimri R, Battelino T, et al. International Consensus on Use of Continuous Glucose Monitoring. Diabetes Care. 2017;40(12):1631-40. DOI:10.2337/dc17-1600
6. Petrie JR, Peters AL, Bergenstal RM, et al. Improving the clinical value and utility of CGM systems: issues and recommendations: A joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group. Diabetologia. 2017;60(12):2319-28. DOI:10.1007/s00125-017-4463-4
7. Demidova TYu, Ushanova FO. Modern technologies for continuous monitoring of glycemia: developing opportunities for check-up and control. RMJ. 2018;11(II):86-90 (in Russian).
8. Suplotova LA, Sudnitsyna AS, Romanova NV, Shestakova MV. Time in range is a tool for assessing the quality of glycemic control in diabetes. Diabetes Mellitus. 2021;24(3):282-90 (in Russian). DOI:10.14341/DM12703
9. Battelino T, Danne T, Bergenstal RM, et al. Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range. Diabetes Care. 2019;42(8):1593-603. DOI:10.2337/dci19-0028

Т.Е. Таранушенко*

ФГБОУ ВО «Красноярский государственный медицинский университет им. проф. В.Ф. Войно-Ясенецкого» Минздрава России, Красноярск, Россия
*tetar@rambler.ru

________________________________________________

Tatiana E. Taranushenko*

Voino-Yasenetsky Krasnoyarsk State Medical University, Krasnoyarsk, Russia
*tetar@rambler.ru